These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 1000500

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Functional activity in vivo of effector T cell populations. III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone.
    Cerundolo V, Lahaye T, Horvath C, Zanovello P, Collavo D, Engers HD.
    Eur J Immunol; 1987 Feb; 17(2):173-8. PubMed ID: 3030766
    [Abstract] [Full Text] [Related]

  • 3. Murine sarcoma virus pseudotypes used as immunogens against viral and chemical oncogenesis.
    Basombrío MA, Mayer AM, Pasqualini CD.
    Cancer Res; 1977 Jun; 37(6):1768-76. PubMed ID: 192461
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cell-mediated immunity to Moloney sarcoma virus in mice. II. Analysis of antigenic specificities involved in T lymphocyte-mediated in vivo rejection of murine sarcoma virus-induced tumors.
    Gorczynski RM, Knight RA.
    Eur J Immunol; 1975 Feb; 5(2):148-55. PubMed ID: 1086221
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
    Collavo D, Ronchese F, Zanovello P, Biasi G, Chieco-Bianchi L.
    J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385
    [No Abstract] [Full Text] [Related]

  • 8. Monoclonal antibody against IFN-gamma inhibits Moloney murine sarcoma virus-specific cytotoxic T lymphocyte differentiation.
    Zanovello P, Vallerani E, Biasi G, Landolfo S, Collavo D.
    J Immunol; 1988 Feb 15; 140(4):1341-4. PubMed ID: 2830339
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Quantitative dose-response relationships of murine sarcoma virus (Moloney) in BALB/c mice.
    Blumenschein GR, Moloney JB.
    J Natl Cancer Inst; 1969 Jan 15; 42(1):123-33. PubMed ID: 5765223
    [No Abstract] [Full Text] [Related]

  • 11. Primary and secondary in vitro generation of cytolytic T lymphocytes in the murine sarcoma virus system.
    Plata F, Cerottini JC, Brunner KT.
    Eur J Immunol; 1975 Apr 15; 5(4):227-33. PubMed ID: 185057
    [Abstract] [Full Text] [Related]

  • 12. Role of accessory cells in the induction of a secondary cytotoxic response to Moloney murine sarcoma virus-induced tumors.
    Biasi G, Saggin L, Dazzi F, De Rossi A, Collavo D.
    J Immunol; 1983 Mar 15; 130(3):1447-50. PubMed ID: 6185589
    [Abstract] [Full Text] [Related]

  • 13. Role of adhesion molecules in the immune reaction to M-MSV-induced tumors.
    Rosato A, Bronte V, Mandruzzato S, Zambon A, Calderazzo F, Biasi G, Zanovello P, Collavo D.
    Int J Cancer Suppl; 1992 Mar 15; 7():24-7. PubMed ID: 1385341
    [Abstract] [Full Text] [Related]

  • 14. Antibody production and interaction with lymphoid cells in relation to tumor immunity in the Moloney sarcoma virus system.
    Harada M, Pearson G, Redmon L, Winters E, Kasuga S.
    J Immunol; 1975 Apr 15; 114(4):1318-22. PubMed ID: 1090675
    [Abstract] [Full Text] [Related]

  • 15. Antibody-dependent lymphocyte cytotoxicity in the murine sarcoma virus system: activity of IgM and IgG with specificity for MLV determined antigen(s).
    Lamon EW, Skurzak HM, Andersson B, Whitten HD, Klein E.
    J Immunol; 1975 Apr 15; 114(4):1171-6. PubMed ID: 1117138
    [Abstract] [Full Text] [Related]

  • 16. Moloney murine sarcoma virus 349 induces Kaposi's sarcomalike lesions in Balb/c mice.
    Stoica G, Hoffman J, Yuen PH.
    Am J Pathol; 1990 Apr 15; 136(4):933-47. PubMed ID: 2158239
    [Abstract] [Full Text] [Related]

  • 17. Vaccination of adult and newborn mice of a resistant strain (C57BL/6J) against challenge with leukemias induced by Moloney murine leukemia virus.
    Reif AE.
    Cancer Res; 1985 Jan 15; 45(1):25-31. PubMed ID: 3965136
    [Abstract] [Full Text] [Related]

  • 18. Platelet-derived growth factor (PDGF) enhances the growth of Moloney sarcoma virus-induced tumors in mice.
    Inglot AD, Inglot O.
    Arch Immunol Ther Exp (Warsz); 1981 Jan 15; 29(4):431-7. PubMed ID: 7332446
    [Abstract] [Full Text] [Related]

  • 19. Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes.
    Flyer DC, Burakoff SJ, Faller DV.
    J Immunol; 1985 Oct 15; 135(4):2287-92. PubMed ID: 2411792
    [Abstract] [Full Text] [Related]

  • 20. T cell-mediated immunity to oncornavirus-induced tumors. IV. Preliminary evidence for a specific suppression of anti-Moloney cell-mediated immune response by autoimmune T cells.
    Leclerc JC, Plater C, Connan F, Debré P.
    Eur J Immunol; 1981 Jan 15; 11(1):45-7. PubMed ID: 6452279
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.